Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)

This study has been terminated.

(Sponsor stopped due to difficulties to recruit 130 patients required by protocol)

Sponsor:

Information provided by (Responsible Party):

Clinica Universidad de Navarra, Universidad de Navarra

ClinicalTrials.gov Identifier:

NCT00324558

First received: May 9, 2006

Last updated: June 7, 2012

Last verified: June 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	September 2010
Primary Completion Date:	February 2010 (Final data collection date for primary outcome measure)